Categories AlphaGraphs, Earnings, Finance

Infographic: CME Group Q4 adj. profit jumps on strong revenue growth

CME Group Inc. (NASDAQ: CME), which operates a derivatives exchange, on Wednesday reported a double-digit increase in adjusted profit for the fourth quarter of 2023. Earnings benefited from a 19% revenue growth.

CME Group Q4 2023 earnings infographic

Net income, excluding special items, increased an impressive 23% year-over-year to $2.37 per share in the December quarter from $1.92 per share in the corresponding period of 2022. Unadjusted profit moved up to $804.3 million or $2.24 per share in the fourth quarter from $629.9 million or $1.75 per share in the prior-year quarter.

The bottom line benefited from a 19% increase in revenues to $1.44 billion during the three months. Average daily volume increased to 25.5 million in Q4 from 21.8 million a year earlier.

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top